Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Improving decision-making for patients with dementia and diabetes

Official title: Enhancing Shared Decision-making to Prompt and Guide Individualized Care for People With Alzheimer's Disease and Diabetes

Run by Indiana University · NCT05643144 · Data updated 2026-11-12

This study is trying to help patients with dementia and diabetes, along with their caregivers, make better decisions by testing a new tool that makes it easier to understand glucose monitoring data.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment62 (estimated)
SponsorIndiana University
Academic / other
Locations1 site (Indianapolis, Indiana)
StatusRecruiting
StartedSeptember 29, 2026
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedOctober 5, 2026
Trial IDNCT05643144 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patient-caregiver dyads where the patient has both diabetes and a diagnosis of mild cognitive impairment or Alzheimer's Disease.

Probably not a fit

Patients with terminal illnesses or those using automated insulin delivery systems may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance shared decision-making for patient-caregiver dyads dealing with diabetes and Alzheimer's Disease or related dementias. Participants will undergo semi-structured interviews to identify their needs while using a continuous glucose monitoring (CGM) device. Following a 14-day period of CGM usage, the study will develop an interactive tool to improve the understanding of CGM data for both patients and caregivers. The approach focuses on user-centered design to ensure the tool meets the specific needs of the dyads involved.

Why it matters

Potential benefit: If successful, this study could lead to improved diabetes management and quality of life for patients with dementia.

How similar studies have gone: While there have been studies focusing on diabetes management and decision-making, this specific approach integrating CGM with dementia care is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Patient-Caregiver Dyad Inclusion Criteria:

* patient must have dual diagnosis of MCI or ADRD and diabetes (DM)
* patient must have active prescriptions for DM
* patient must have had at least one visit to an Eskenazi or IU Health primary care clinic within 12 months
* patient must be able to provide assent and have a legally authorized representative (LAR) consent on their behalf if patient lacks capacity to consent
* patient must have a caregiver aged 18 years or older who interacts daily, or almost daily, with the patient
* patient and caregiver must both speak English
* patient and caregiver must both reside in the community
* dyad must have internet access

Patient-Caregiver Dyad Exclusion Criteria:

* patient has terminal illness
* use of an automated insulin delivery system
* patient is receiving dialysis
* patient is taking ascorbic acid during monitoring period
* patient has existing implanted medical devices
* patient has a bleeding disorder
* patient has a pre-existing arm skin lesions
* patient has an allergy to medical adhesive or isopropyl alcohol
* patient has plans for imaging or diathermy treatment during the study period

Where it's running

  • Eskenazi Health
    Indianapolis, Indiana, United States
    Recruiting

Study contacts

  • Principal investigator: April Savoy, PhD — Indiana University
  • Study coordinator: April Savoy, PhD
  • Email: asavoy@iu.edu
  • Phone: 317-278-2194

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.